Boston Partners’s Mead Johnson Nutrition Company MJN Stock Holding History

Boston Partners’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-85,500	Closed	-$6.05M	–	813
2016 Q4	$6.05M	Hold	85,500	–	–	0.01%	464
2016 Q3	$6.75M	Hold	85,500	–	–	0.01%	450
2016 Q2	$7.76M	Hold	85,500	–	–	0.01%	427
2016 Q1	$7.26M	Hold	85,500	–	–	0.01%	414
2015 Q4	$6.75M	Hold	85,500	–	–	0.01%	444
2015 Q3	$6.02M	Hold	85,500	–	–	0.01%	455
2015 Q2	$7.71M	Hold	85,500	–	–	0.01%	439
2015 Q1	$8.6M	Buy	85,500 +500	+0.6%	+$50.4K	0.01%	431
2014 Q4	$8.55M	Sell	85,000 -1,500	-2%	-$150K	0.01%	433
2014 Q3	$8.32M	Buy	86,500 +29,700	+52%	+$2.81M	0.01%	426
2014 Q2	$5.29M	Hold	56,800	–	–	0.01%	508
2014 Q1	$4.72M	Buy	+56,800	New	+$4.6M	0.01%	528

Other funds holding MJN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Boston Partners's MJN Position: Q1 2017 in Review

Boston Partners sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 85,500 shares — an estimated $6.05M sold.

Boston Partners first reported a position in MJN in Q1 2014 and held it in 12 quarters. The position peaked at $8.6M in Q1 2015. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

Boston Partners reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
Boston Partners sold 85,500 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $6.05M.
Boston Partners first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 12 quarters.
Boston Partners's Mead Johnson Nutrition Company position peaked at $8.6M in Q1 2015.
533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Boston Partners's 13F filing for Q1 2017, filed 3 May 2017.